Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 3/20 | 0.46 |
| ▸ | ADH1A | P07327 | 3/20 | 0.46 |
| ▸ | ADH7 | P40394 | 3/20 | 0.46 |
| ▸ | ADH1C | P00326 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | ADH4 | P08319 | 1/20 | 0.44 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.39 |
| ▸ | SMOX | Q9NWM0 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3312972 | 0.85 | — | — | |
| SCHEMBL3023756 | 0.84 | PAOX (0.50) | PAOXSMOXKDM4EALDH1A1NPC1 | |
| SCHEMBL1948513 | 0.84 | KDM1A (0.43) | PAOXSMOXKDM4EALDH1A1NPC1 | |
| SCHEMBL17291809 | 0.82 | PAOX (0.48) | PAOXSMOXKDM4EALDH1A1NPC1 | |
| SCHEMBL5611725 | 0.82 | PAOX (0.48) | PAOXSMOXKDM4EALDH1A1NPC1 | |
| Hydrochloric Acid SCHEMBL3024738 | 0.82 | SMOX (0.52) | PAOXSMOXKDM4EALDH1A1NPC1 | |
| SCHEMBL17291817 | 0.82 | PAOX (0.48) | PAOXSMOXKDM4EALDH1A1NPC1 | |
| SCHEMBL17291829 | 0.82 | PAOX (0.48) | PAOXSMOXKDM4EALDH1A1NPC1 | |
| SCHEMBL17291826 | 0.82 | PAOX (0.48) | PAOXSMOXKDM4EALDH1A1NPC1 | |
| Hydrochloric Acid SCHEMBL3009329 | 0.82 | KDM1A (0.46) | PAOXSMOXKDM4EALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100104659-A1 | BENZOPYRANOPYRAZOLES | 4SC AG (DE) | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100104659-A1 | BENZOPYRANOPYRAZOLES | BAX, BCL2, BAD | ADH1B 1255/4885ADH1A 1695/4885ADH7 1425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.